Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.

Xiaowen Tang, Lin Yang, Zheng Li, +11

PubMed

Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells

Fengtao You, Licui Jiang, Bozhen Zhang, +20

Science China Life Sciences

A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia.

Fengtao You, Yinyan Wang, Licui Jiang, +6

PubMed

ImmunologyImmunoeditingImmunodominanceAntigen ProcessingMdcd7-car-nk-92mi Cells +17

Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma

Mingzhi Zhang, Dan Chen, Xiaorui Fu, +24

Clinical Cancer Research

<p>Decitabine enhances cytotoxic effect of T cells with an anti-CD19 chimeric antigen receptor in treatment of lymphoma</p>

Sujun Li, Lei Xue, Min Wang, +10

OncoTargets and Therapy

Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody

Ying Chen, Fengtao You, Licui Jiang, +9

Oncotarget

Cancer-killing AbilityTumor ImmunologyNk-92mi CellsCancer ImmunosurveillanceMedicine +13

MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity.

Xiaochen Zhai, Fengtao You, Shufen Xiang, +11

PubMed

First-in-human clinical trial of the autologous CD7-CART for relapsed/refractory ACUTE lymphoblastic leukemia/lymphoma.

Mingzhi Zhang, Lin Yang, Xiaorui Fu, +17

Journal of Clinical Oncology

Cell TherapyImmunologyImmunoeditingPathologyCd4 T Cell Responses +20

A Single-Arm, Open-Label, Pilot Trial of Autologous CD7-CAR-T Cells for CD7 Positive Relapsed and Refractory T-Lymphoblastic Leukemia/Lymphoma

Mingzhi Zhang, Xiaorui Fu, Huimin Meng, +20

Blood

Preconditioning of radiotherapy enhances efficacy of B7-H3-CAR-T in treating solid tumor models

Tian Wang, Kailu Zhang, Fengtao You, +5

Life Sciences